TY - JOUR AU - Slamon, D. J. AU - Clark, G. M. AU - Wong, S. G. AU - Levin, W. J. AU - Ullrich, A. AU - McGuire, W. L. PY - 1987 DA - 1987// TI - Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene JO - Science. VL - 235 UR - https://doi.org/10.1126/science.3798106 DO - 10.1126/science.3798106 ID - Slamon1987 ER - TY - JOUR AU - Chia, S. AU - Norris, B. AU - Speers, C. AU - Cheang, M. AU - Gilks, B. AU - Gown, A. M. PY - 2008 DA - 2008// TI - Human epidermal growth factor receptor 2 overexpression as a prognostic factor in a large tissue microarray series of node-negative breast cancers JO - J Clin Oncol. VL - 26 UR - https://doi.org/10.1200/JCO.2007.15.8659 DO - 10.1200/JCO.2007.15.8659 ID - Chia2008 ER - TY - JOUR AU - Slamon, D. J. AU - Leyland-Jones, B. AU - Shak, S. AU - Fuchs, H. AU - Paton, V. AU - Bajamonde, A. PY - 2001 DA - 2001// TI - Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2 JO - N Engl J Med. VL - 344 UR - https://doi.org/10.1056/NEJM200103153441101 DO - 10.1056/NEJM200103153441101 ID - Slamon2001 ER - TY - JOUR AU - Geyer, C. E. AU - Forster, J. AU - Lindquist, D. AU - Chan, S. AU - Romieu, C. G. AU - Pienkowski, T. PY - 2006 DA - 2006// TI - Lapatinib plus capecitabine for HER2-positive advanced breast cancer JO - N Engl J Med. VL - 355 UR - https://doi.org/10.1056/NEJMoa064320 DO - 10.1056/NEJMoa064320 ID - Geyer2006 ER - TY - JOUR AU - Sauter, G. AU - Lee, J. AU - Bartlett, J. M. AU - Slamon, D. J. AU - Press, M. F. PY - 2009 DA - 2009// TI - Guidelines for human epidermal growth factor receptor 2 testing: biologic and methodologic considerations JO - J Clinical Oncol. VL - 27 UR - https://doi.org/10.1200/JCO.2007.14.8197 DO - 10.1200/JCO.2007.14.8197 ID - Sauter2009 ER - TY - JOUR AU - Ahmed, S. S. AU - Iqbal, J. AU - Thike, A. A. AU - Lim, A. S. AU - Lim, T. H. AU - Tien, S. L. PY - 2011 DA - 2011// TI - HER2/neu revisited: quality and interpretive issues JO - J Clin Pathol. VL - 64 UR - https://doi.org/10.1136/jcp.2010.085423 DO - 10.1136/jcp.2010.085423 ID - Ahmed2011 ER - TY - JOUR AU - De, P. AU - Smith, B. R. AU - Leyland-Jones, B. PY - 2010 DA - 2010// TI - Human epidermal growth factor receptor 2 testing: where are we? JO - J Clin Oncol. VL - 28 UR - https://doi.org/10.1200/JCO.2010.29.5071 DO - 10.1200/JCO.2010.29.5071 ID - De2010 ER - TY - JOUR AU - Vogel, U. F. PY - 2010 DA - 2010// TI - Confirmation of a low HER2 positivity rate of breast carcinomas - limitations of immunohistochemistry and in situ hybridization JO - Diagn Pathol. VL - 5 ID - Vogel2010 ER - TY - JOUR AU - Ross, J. S. PY - 2009 DA - 2009// TI - Breast cancer biomarkers and HER2 testing after 10 years of anti-HER2 therapy JO - Drug News Perspect. VL - 22 UR - https://doi.org/10.1358/dnp.2009.22.2.1334452 DO - 10.1358/dnp.2009.22.2.1334452 ID - Ross2009 ER - TY - JOUR AU - Wolff, A. C. AU - Hammond, M. E. AU - Hicks, D. G. AU - Dowsett, M. AU - McShane, L. M. AU - Allison, K. H. PY - 2014 DA - 2014// TI - Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update JO - Arch Pathol Lab Med. VL - 138 UR - https://doi.org/10.5858/arpa.2013-0953-SA DO - 10.5858/arpa.2013-0953-SA ID - Wolff2014 ER - TY - JOUR AU - Shah, S. S. AU - Ketterling, R. P. AU - Goetz, M. P. AU - Ingle, J. N. AU - Reynolds, C. A. AU - Perez, E. A. PY - 2010 DA - 2010// TI - Impact of American Society of Clinical Oncology/College of American Pathologists guideline recommendations on HER2 interpretation in breast cancer JO - Hum Pathol. VL - 41 UR - https://doi.org/10.1016/j.humpath.2009.07.001 DO - 10.1016/j.humpath.2009.07.001 ID - Shah2010 ER - TY - JOUR AU - Perez, E. A. AU - Suman, V. J. AU - Davidson, N. E. AU - Martino, S. AU - Kaufman, P. A. AU - Lingle, W. L. PY - 2006 DA - 2006// TI - HER2 testing by local, central, and reference laboratories in specimens from the North Central Cancer Treatment Group N9831 intergroup adjuvant trial JO - J Clin Oncol. VL - 24 UR - https://doi.org/10.1200/JCO.2005.03.4744 DO - 10.1200/JCO.2005.03.4744 ID - Perez2006 ER - TY - JOUR AU - Perez, E. A. AU - Reinholz, M. M. AU - Hillman, D. W. AU - Tenner, K. S. AU - Schroeder, M. J. AU - Davidson, N. E. PY - 2010 DA - 2010// TI - HER2 and chromosome 17 effect on patient outcome in the N9831 adjuvant trastuzumab trial JO - J Clin Oncol. VL - 28 UR - https://doi.org/10.1200/JCO.2009.26.2154 DO - 10.1200/JCO.2009.26.2154 ID - Perez2010 ER - TY - JOUR AU - Press, M. F. AU - Finn, R. S. AU - Cameron, D. AU - Leo, A. AU - Geyer, C. E. AU - Villalobos, I. E. PY - 2008 DA - 2008// TI - HER-2 gene amplification, HER-2 and epidermal growth factor receptor mRNA and protein expression, and lapatinib efficacy in women with metastatic breast cancer JO - Clin Cancer Res. VL - 14 UR - https://doi.org/10.1158/1078-0432.CCR-08-1056 DO - 10.1158/1078-0432.CCR-08-1056 ID - Press2008 ER - TY - JOUR AU - Press, M. F. AU - Sauter, G. AU - Bernstein, L. AU - Villalobos, I. E. AU - Mirlacher, M. AU - Zhou, J. Y. PY - 2005 DA - 2005// TI - Diagnostic evaluation of HER-2 as a molecular target: an assessment of accuracy and reproducibility of laboratory testing in large, prospective, randomized clinical trials JO - Clin Cancer Res. VL - 11 UR - https://doi.org/10.1158/1078-0432.CCR-05-0636 DO - 10.1158/1078-0432.CCR-05-0636 ID - Press2005 ER - TY - JOUR AU - Press, M. F. AU - Slamon, D. J. AU - Flom, K. J. AU - Park, J. AU - Zhou, J. Y. AU - Bernstein, L. PY - 2002 DA - 2002// TI - Evaluation of HER-2/neu gene amplification and overexpression: comparison of frequently used assay methods in a molecularly characterized cohort of breast cancer specimens JO - J Clin Oncol. VL - 20 ID - Press2002 ER - TY - JOUR AU - Paik, S. AU - Kim, C. AU - Wolmark, N. PY - 2008 DA - 2008// TI - HER2 status and benefit from adjuvant trastuzumab in breast cancer JO - N Engl J Med. VL - 358 UR - https://doi.org/10.1056/NEJMc0801440 DO - 10.1056/NEJMc0801440 ID - Paik2008 ER - TY - JOUR AU - Paik, S. AU - Kim, C. AU - Jeong, J. AU - Geyer, C. E. AU - Romond, E. AU - Mejia-Mejia, O. PY - 2007 DA - 2007// TI - Benefit from adjuvant trastuzumab may not be confined to patients with IHC 3+ and/or FISH-positive tumors: Central testing results from NSABP B-31 JO - J Clin Oncol. VL - 25 ID - Paik2007 ER - TY - JOUR AU - Dowsett, M. AU - Procter, M. AU - McCaskill-Stevens, W. AU - Azambuja, E. AU - Dafni, U. AU - Rueschoff, J. PY - 2009 DA - 2009// TI - Disease-free survival according to degree of HER2 amplification for patients treated with adjuvant chemotherapy with or without 1 year of trastuzumab: the HERA Trial JO - J Clin Oncol. VL - 27 UR - https://doi.org/10.1200/JCO.2008.19.7939 DO - 10.1200/JCO.2008.19.7939 ID - Dowsett2009 ER - TY - JOUR AU - Cronin, M. AU - Pho, M. AU - Dutta, D. AU - Stephans, J. C. AU - Shak, S. AU - Kiefer, M. C. PY - 2004 DA - 2004// TI - Measurement of gene expression in archival paraffin-embedded tissues: development and performance of a 92-gene reverse transcriptase-polymerase chain reaction assay JO - Am J Pathol. VL - 164 UR - https://doi.org/10.1016/S0002-9440(10)63093-3 DO - 10.1016/S0002-9440(10)63093-3 ID - Cronin2004 ER - TY - JOUR AU - Cronin, M. AU - Sangli, C. AU - Liu, M. L. AU - Pho, M. AU - Dutta, D. AU - Nguyen, A. PY - 2007 DA - 2007// TI - Analytical validation of the Oncotype DX genomic diagnostic test for recurrence prognosis and therapeutic response prediction in node-negative, estrogen receptor-positive breast cancer JO - Clin Chem. VL - 53 UR - https://doi.org/10.1373/clinchem.2006.076497 DO - 10.1373/clinchem.2006.076497 ID - Cronin2007 ER - TY - JOUR AU - Baehner, F. L. AU - Achacoso, N. AU - Maddala, T. AU - Shak, S. AU - Quesenberry, C. P. AU - Goldstein, L. C. PY - 2010 DA - 2010// TI - Human epidermal growth factor receptor 2 assessment in a case-control study: comparison of fluorescence in situ hybridization and quantitative reverse transcription polymerase chain reaction performed by central laboratories JO - J Clin Oncol. VL - 28 UR - https://doi.org/10.1200/JCO.2009.24.8211 DO - 10.1200/JCO.2009.24.8211 ID - Baehner2010 ER - TY - BOOK AU - Badve, S. AU - Gray, R. AU - Childs, B. H. AU - Maddala, T. AU - Liu, M. L. AU - Rowley, S. PY - 2008 DA - 2008// TI - HER2 concordance between central laboratory immunohistochemistry and quantitative reverse transcription polymerase chain reaction in intergroup trial E2197 PB - ASCO Breast CY - Washington DC ID - Badve2008 ER - TY - JOUR AU - Lehmann-Che, J. AU - Amira-Bouhidel, F. AU - Turpin, E. AU - Antoine, M. AU - Soliman, H. AU - Legres, L. PY - 2011 DA - 2011// TI - Immunohistochemical and molecular analyses of HER2 status in breast cancers are highly concordant and complementary approaches JO - Br J Cancer. VL - 104 UR - https://doi.org/10.1038/bjc.2011.135 DO - 10.1038/bjc.2011.135 ID - Lehmann-Che2011 ER - TY - JOUR AU - Christgen, M. AU - Harbeck, N. AU - Gluz, O. AU - Nitz, U. AU - Kreipe, H. H. PY - 2012 DA - 2012// TI - Recognition and handling of discordant negative human epidermal growth factor receptor 2 classification by Oncotype DX in patients with breast cancer JO - J Clin Oncol. VL - 30 UR - https://doi.org/10.1200/JCO.2012.42.1990 DO - 10.1200/JCO.2012.42.1990 ID - Christgen2012 ER - TY - JOUR AU - Park, S. AU - Wang, H. Y. AU - Kim, S. AU - Ahn, S. AU - Lee, D. AU - Cho, Y. PY - 2014 DA - 2014// TI - Quantitative RT-PCR assay of HER2 mRNA expression in formalin-fixed and paraffin-embedded breast cancer tissues JO - Int J Clin Exp Pathol. VL - 7 ID - Park2014 ER - TY - JOUR AU - Fiore, P. P. AU - Pierce, J. H. AU - Kraus, M. H. AU - Segatto, O. AU - King, C. R. AU - Aaronson, S. A. PY - 1987 DA - 1987// TI - erbB-2 is a potent oncogene when overexpressed in NIH/3T3 cells JO - Science VL - 237 UR - https://doi.org/10.1126/science.2885917 DO - 10.1126/science.2885917 ID - Fiore1987 ER - TY - JOUR AU - Coussens, L. AU - Yang-Feng, T. L. AU - Liao, Y. C. AU - Chen, E. AU - Gray, A. AU - McGrath, J. PY - 1985 DA - 1985// TI - Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene JO - Science. VL - 230 UR - https://doi.org/10.1126/science.2999974 DO - 10.1126/science.2999974 ID - Coussens1985 ER - TY - JOUR AU - Wolff, A. C. AU - Hammond, M. E. AU - Schwartz, J. N. AU - Hagerty, K. L. AU - Allred, D. C. AU - Cote, R. J. PY - 2007 DA - 2007// TI - American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer JO - J Clin Oncol. VL - 25 UR - https://doi.org/10.1200/JCO.2006.09.2775 DO - 10.1200/JCO.2006.09.2775 ID - Wolff2007 ER - TY - JOUR AU - Perez, E. A. AU - Suman, V. J. AU - Davidson, N. E. AU - Gralow, J. R. AU - Kaufman, P. A. AU - Visscher, D. W. PY - 2011 DA - 2011// TI - Sequential versus concurrent trastuzumab in adjuvant chemotherapy for breast cancer JO - J Clin Oncol. VL - 29 UR - https://doi.org/10.1200/JCO.2011.36.7045 DO - 10.1200/JCO.2011.36.7045 ID - Perez2011 ER - TY - JOUR AU - Perez, E. A. AU - Roche, P. C. AU - Jenkins, R. B. AU - Reynolds, C. A. AU - Halling, K. C. AU - Ingle, J. N. PY - 2002 DA - 2002// TI - HER2 testing in patients with breast cancer: poor correlation between weak positivity by immunohistochemistry and gene amplification by fluorescence in situ hybridization JO - Mayo Clin Proc. VL - 77 UR - https://doi.org/10.1016/S0025-6196(11)62329-X DO - 10.1016/S0025-6196(11)62329-X ID - Perez2002 ER - TY - JOUR AU - Roche, P. C. AU - Suman, V. J. AU - Jenkins, R. B. AU - Davidson, N. E. AU - Martino, S. AU - Kaufman, P. A. PY - 2002 DA - 2002// TI - Concordance between local and central laboratory HER2 testing in the breast intergroup trial N9831 JO - J Natl Cancer Inst. VL - 94 UR - https://doi.org/10.1093/jnci/94.11.855 DO - 10.1093/jnci/94.11.855 ID - Roche2002 ER - TY - JOUR AU - Bose, S. AU - Mohammed, M. AU - Shintaku, P. AU - Rao, P. N. PY - 2001 DA - 2001// TI - Her-2/neu gene amplification in low to moderately expressing breast cancers: possible role of chromosome 17/Her-2/neu polysomy JO - Breast J. VL - 7 UR - https://doi.org/10.1046/j.1524-4741.2001.21018.x DO - 10.1046/j.1524-4741.2001.21018.x ID - Bose2001 ER - TY - JOUR AU - Morrison, L. E. AU - Jewell, S. S. AU - Usha, L. AU - Blondin, B. A. AU - Rao, R. D. AU - Tabesh, B. PY - 2007 DA - 2007// TI - Effects of ERBB2 amplicon size and genomic alterations of chromosomes 1, 3, and 10 on patient response to trastuzumab in metastatic breast cancer JO - Genes Chromosomes Cancer. VL - 46 UR - https://doi.org/10.1002/gcc.20419 DO - 10.1002/gcc.20419 ID - Morrison2007 ER - TY - JOUR AU - Reinholz, M. M. AU - Bruzek, A. K. AU - Visscher, D. W. AU - Lingle, W. L. AU - Schroeder, M. J. AU - Perez, E. A. PY - 2009 DA - 2009// TI - Breast cancer and aneusomy 17: implications for carcinogenesis and therapeutic response JO - Lancet Oncol. VL - 10 UR - https://doi.org/10.1016/S1470-2045(09)70063-4 DO - 10.1016/S1470-2045(09)70063-4 ID - Reinholz2009 ER - TY - JOUR AU - Vanden Bempt, I. AU - Drijkoningen, M. AU - Wolf-Peeters, C. PY - 2007 DA - 2007// TI - The complexity of genotypic alterations underlying HER2-positive breast cancer: an explanation for its clinical heterogeneity JO - Curr Opin Oncol. VL - 19 UR - https://doi.org/10.1097/CCO.0b013e3282f0ad8e DO - 10.1097/CCO.0b013e3282f0ad8e ID - Vanden Bempt2007 ER - TY - JOUR AU - Zaczek, A. AU - Welnicka-Jaskiewicz, M. AU - Bielawski, K. P. AU - Jaskiewicz, J. AU - Badzio, A. AU - Olszewski, W. PY - 2008 DA - 2008// TI - Gene copy numbers of HER family in breast cancer JO - J Cancer Res Clin Oncol. VL - 134 UR - https://doi.org/10.1007/s00432-007-0284-z DO - 10.1007/s00432-007-0284-z ID - Zaczek2008 ER - TY - JOUR AU - Westgard, J. O. AU - Barry, P. L. AU - Hunt, M. R. AU - Groth, T. PY - 1981 DA - 1981// TI - A multi-rule Shewhart chart for quality control in clinical chemistry JO - Clin Chem. VL - 27 ID - Westgard1981 ER - TY - JOUR AU - Paik, S. AU - Shak, S. AU - Tang, G. AU - Kim, C. AU - Baker, J. AU - Cronin, M. PY - 2004 DA - 2004// TI - A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer JO - N Engl J Med. VL - 351 UR - https://doi.org/10.1056/NEJMoa041588 DO - 10.1056/NEJMoa041588 ID - Paik2004 ER - TY - JOUR AU - Elston, C. W. AU - Ellis, I. O. PY - 1991 DA - 1991// TI - Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up JO - Histopathology VL - 19 UR - https://doi.org/10.1111/j.1365-2559.1991.tb00229.x DO - 10.1111/j.1365-2559.1991.tb00229.x ID - Elston1991 ER - TY - BOOK AU - Elston, C. W. AU - Ellis, I. O. PY - 1999 DA - 1999// TI - The breast, vol. 13. 3rd ed PB - Churchill Livingstone CY - London ID - Elston1999 ER - TY - BOOK PY - 2003 DA - 2003// TI - World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Breast and Female Genital Organs PB - IARC Press CY - Lyon ID - ref42 ER - TY - JOUR AU - Cobleigh, M. A. AU - Tabesh, B. AU - Bitterman, P. AU - Baker, J. AU - Cronin, M. AU - Liu, M. L. PY - 2005 DA - 2005// TI - Tumor gene expression and prognosis in breast cancer patients with 10 or more positive lymph nodes JO - Clin Cancer Res. VL - 11 UR - https://doi.org/10.1158/1078-0432.CCR-05-0735 DO - 10.1158/1078-0432.CCR-05-0735 ID - Cobleigh2005 ER - TY - JOUR AU - Esteva, F. J. AU - Sahin, A. A. AU - Cristofanilli, M. AU - Coombes, K. AU - Lee, S. J. AU - Baker, J. PY - 2005 DA - 2005// TI - Prognostic role of a multigene reverse transcriptase-PCR assay in patients with node-negative breast cancer not receiving adjuvant systemic therapy JO - Clin Cancer Res. VL - 11 UR - https://doi.org/10.1158/1078-0432.CCR-04-1707 DO - 10.1158/1078-0432.CCR-04-1707 ID - Esteva2005 ER - TY - JOUR AU - Mina, L. AU - Soule, S. E. AU - Badve, S. AU - Baehner, F. L. AU - Baker, J. AU - Cronin, M. PY - 2007 DA - 2007// TI - Predicting response to primary chemotherapy: gene expression profiling of paraffin-embedded core biopsy tissue JO - Breast Cancer Res Treat. VL - 103 UR - https://doi.org/10.1007/s10549-006-9366-x DO - 10.1007/s10549-006-9366-x ID - Mina2007 ER - TY - JOUR AU - Chang, J. C. AU - Makris, A. AU - Gutierrez, M. C. AU - Hilsenbeck, S. G. AU - Hackett, J. R. AU - Jeong, J. PY - 2008 DA - 2008// TI - Gene expression patterns in formalin-fixed, paraffin-embedded core biopsies predict docetaxel chemosensitivity in breast cancer patients JO - Breast Cancer Res Treat. VL - 108 UR - https://doi.org/10.1007/s10549-007-9590-z DO - 10.1007/s10549-007-9590-z ID - Chang2008 ER - TY - JOUR AU - Wolff, A. C. AU - Hammond, M. E. AU - Hicks, D. G. AU - Dowsett, M. AU - McShane, L. M. AU - Allison, K. H. PY - 2013 DA - 2013// TI - Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update JO - J Clin Oncol. VL - 31 UR - https://doi.org/10.1200/JCO.2013.50.9984 DO - 10.1200/JCO.2013.50.9984 ID - Wolff2013 ER - TY - JOUR AU - Konecny, G. AU - Pauletti, G. AU - Pegram, M. AU - Untch, M. AU - Dandekar, S. AU - Aguilar, Z. PY - 2003 DA - 2003// TI - Quantitative association between HER-2/neu and steroid hormone receptors in hormone receptor-positive primary breast cancer JO - J Natl Cancer Inst. VL - 95 UR - https://doi.org/10.1093/jnci/95.2.142 DO - 10.1093/jnci/95.2.142 ID - Konecny2003 ER - TY - JOUR AU - Wirapati, P. AU - Sotiriou, C. AU - Kunkel, S. AU - Farmer, P. AU - Pradervand, S. AU - Haibe-Kains, B. PY - 2008 DA - 2008// TI - Meta-analysis of gene expression profiles in breast cancer: toward a unified understanding of breast cancer subtyping and prognosis signatures JO - Breast Cancer Res. VL - 10 UR - https://doi.org/10.1186/bcr2124 DO - 10.1186/bcr2124 ID - Wirapati2008 ER - TY - JOUR AU - Pogue-Geile, K. L. AU - Kim, C. AU - Jeong, J. H. AU - Tanaka, N. AU - Bandos, H. AU - Gavin, P. G. PY - 2013 DA - 2013// TI - Predicting degree of benefit from adjuvant trastuzumab in NSABP trial B-31 JO - J Natl Cancer Inst. VL - 105 UR - https://doi.org/10.1093/jnci/djt321 DO - 10.1093/jnci/djt321 ID - Pogue-Geile2013 ER - TY - JOUR AU - Perez, E. A. AU - Thompson, E. A. AU - Ballman, K. V. AU - Anderson, S. K. AU - Asmann, Y. W. AU - Kalari, K. R. PY - 2015 DA - 2015// TI - Genomic analysis reveals that immune function genes are strongly linked to clinical outcome in the North Central Cancer Treatment Group n9831 adjuvant trastuzumab trial JO - J Clin Oncol. VL - 33 UR - https://doi.org/10.1200/JCO.2014.57.6298 DO - 10.1200/JCO.2014.57.6298 ID - Perez2015 ER - TY - JOUR AU - Gown, A. M. AU - Goldstein, L. C. AU - Barry, T. S. AU - Kussick, S. J. AU - Kandalaft, P. L. AU - Kim, P. M. PY - 2008 DA - 2008// TI - High concordance between immunohistochemistry and fluorescence in situ hybridization testing for HER2 status in breast cancer requires a normalized IHC scoring system JO - Mod Pathol. VL - 21 UR - https://doi.org/10.1038/modpathol.2008.83 DO - 10.1038/modpathol.2008.83 ID - Gown2008 ER - TY - BOOK AU - Ming, Z. AU - Bronner, M. AU - Magi-Galluzzi, C. AU - Tuthhill, R. AU - Baehner, F. L. AU - Liu, M. L. PY - 2007 DA - 2007// TI - Optimized RNA extraction and RT-PCR assays provide successful molecular analysis on a wide variety of archival fixed tissues PB - Los Angeles CY - American Association for Cancer Research ID - Ming2007 ER - TY - STD TI - Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A, et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 2002;3:RESEARCH0034. ID - ref54 ER - TY - JOUR AU - Suzuki, T. AU - Higgins, P. J. AU - Crawford, D. R. PY - 2000 DA - 2000// TI - Control selection for RNA quantitation JO - Biotechniques. VL - 29 ID - Suzuki2000 ER - TY - JOUR AU - Tapia, C. AU - Schraml, P. AU - Simon, R. AU - Al-Kuraya, K. S. AU - Maurer, R. AU - Mirlacher, M. PY - 2004 DA - 2004// TI - HER2 analysis in breast cancer: reduced immunoreactivity in FISH non-informative cancer biopsies JO - Int J Oncol. VL - 25 ID - Tapia2004 ER - TY - JOUR AU - Khoury, T. AU - Sait, S. AU - Hwang, H. AU - Chandrasekhar, R. AU - Wilding, G. AU - Tan, D. PY - 2009 DA - 2009// TI - Delay to formalin fixation effect on breast biomarkers JO - Mod Pathol. VL - 22 UR - https://doi.org/10.1038/modpathol.2009.117 DO - 10.1038/modpathol.2009.117 ID - Khoury2009 ER - TY - JOUR AU - Dabbs, D. J. AU - Klein, M. E. AU - Mohsin, S. K. AU - Tubbs, R. R. AU - Shuai, Y. AU - Bhargava, R. PY - 2011 DA - 2011// TI - High false-negative rate of HER2 quantitative reverse transcription polymerase chain reaction of the Oncotype DX test: an independent quality assurance study JO - J Clin Oncol. VL - 29 UR - https://doi.org/10.1200/JCO.2011.34.7963 DO - 10.1200/JCO.2011.34.7963 ID - Dabbs2011 ER - TY - JOUR AU - Bartlett, J. M. AU - Starczynski, J. PY - 2011 DA - 2011// TI - Quantitative reverse transcriptase polymerase chain reaction and the Oncotype DX test for assessment of human epidermal growth factor receptor 2 status: time to reflect again? JO - J Clin Oncol. VL - 29 UR - https://doi.org/10.1200/JCO.2011.37.5824 DO - 10.1200/JCO.2011.37.5824 ID - Bartlett2011 ER - TY - JOUR AU - Park, M. M. AU - Ebel, J. J. AU - Zhao, W. AU - Zynger, D. L. PY - 2014 DA - 2014// TI - ER and PR immunohistochemistry and HER2 FISH versus oncotype DX: implications for breast cancer treatment JO - Breast J. VL - 20 UR - https://doi.org/10.1111/tbj.12223 DO - 10.1111/tbj.12223 ID - Park2014 ER - TY - JOUR AU - Dvorak, L. AU - Dolan, M. AU - Fink, J. AU - Varghese, L. AU - Henriksen, J. AU - Gulbahce, H. E. PY - 2013 DA - 2013// TI - Correlation between HER2 determined by fluorescence in situ hybridization and reverse transcription-polymerase chain reaction of the oncotype DX test JO - Appl Immunohistochem Mol Morphol VL - 21 ID - Dvorak2013 ER - TY - JOUR AU - Yaziji, H. AU - Goldstein, L. C. AU - Barry, T. S. AU - Werling, R. AU - Hwang, H. AU - Ellis, G. K. PY - 2004 DA - 2004// TI - HER-2 testing in breast cancer using parallel tissue-based methods JO - JAMA. VL - 291 UR - https://doi.org/10.1001/jama.291.16.1972 DO - 10.1001/jama.291.16.1972 ID - Yaziji2004 ER -